The AHA! Moment
After an incredibly frustrating tap, an AHA! moment struck for Dr. Alverson and Dr. D’Cruz.
Brian, a nationally recognized Hospitalist and Ravi, an ex-Architect turned Doctor, teamed up to solve the multiple challenges and stressors inherent in Infant Spinal Taps. Like all great ‘in the room’ stories, this one is best told first person. Watch the video and learn from them how this inspirational device was created.
Our Mission
To increase the success rates and improve the experience during infant spinal tap procedures.
Meet the Team
The power of the SMöLTAP idea was self-evident to thought leaders from across clinical, operational, and patient experience domains. The project now enjoys the support, insight, and development expertise of a highly interdisciplinary team.
Embracing the smallest patients
The word “smol” began as an internet meme that started circa 2018 as a web short-hand for “small.” In online parlance the word has come to mean not just small, but ‘adorably small’ in stature. It can relate to things, pets, people, and concepts, like SMöLTAP. We embrace its warm, welcoming sensibility to signal the transformative change we bring to a procedure with an outsize impact on our smallest patients.
Investors
We enjoy the early-stage backing of leading biomedical innovation
investors from the region and the world.
New England Medical Innovation Center
New England Medical Center (NEMIC) is a Med Tech venture hub that provides expert support, education, funding connections, and specialized expertise to innovators and entrepreneurs in the medical technologies space. We support the growth of startups by connecting teams to SMEs, facilitating clinical access, and providing a creative, productive co-working space where they can transform their medtech ideas into fundable and sustainable solutions.
The Charles H. Hood Foundation
The Charles H. Hood Foundation serves as a catalyst for positive change by funding emerging research that transforms the lives of children. By identifying innovative pediatric advancements and providing funding in the critical phases of development, we are able to expedite high-impact breakthroughs that improve the health and lives of millions.
Brown Biomedical Innovations Impact Fund
The Brown Biomedical Innovations to Impact (BBII) fund is an academic accelerator fund dedicated to supporting academic biomedical technologies—with potential for high impact—to become well-defined product opportunities that are attractive to industry partners and investors.
A collaboration between the Brown Technology Innovations group and the Division of Biology and Medicine, BBII achieves its goals by funding translational research projects, advising and coaching teams, managing consulting and research collaborators, and exploring commercial development opportunities as initiatives progress